9h45

OPENING CEREMONY

Amphithéâtre Bordeaux

E. ALIOT, Nancy

P. JAIS, Bordeaux

10h00

SESSION 1: THE FIBRILLATING HEART: ATRIAL FIBRILLATIONWITH THE SUPPORT OF BOSTON SCIENTIFIC

Amphithéâtre Bordeaux

Mélèze HOCINI, Bordeaux - FRA & J.KORUTH, New-York - USA

Anatomical consideration for AF ablation: septo-pulmonary bundle and mitral isthmus

- Septo-pulmonary bundle and coronary sinus musculature: anatomist consideration on epicardial left atrial layers

J.A. CABRERA, MADRID - ES

- Septo-pulmonary bundle and coronary sinus musculature: clinical implication for linear block achievement

T.PAMBRU, BORDEAUX - FRA

What is the rationale for VoM alcoholisation? Pre-recorded case of VoM alcoholisation

N. DERVAL, Bordeaux – FRA

CHARISMA, contact force and local impedance

A. LEPILLIER, SAINT DENIS - FRA

Pre-recorded case on ablation by left atrial wall thickness

A. BERRUEZO, Barcelona – ES

Epi-endo asynchrony during AF

TUNG, Chicago – USA

PFA for paroxysmal and persistent AF, lessons from real life experience (MANIFEST)

J. KORUTH, New-York – USA

Discussion 35'

13h30

SESSION 2: THE FIBRILLATING HEART: ATRIAL FIBRILLATION WITH THE SUPPORT OF MEDTRONIC

Amphithéâtre Bordeaux

J.SEITZ, Marseille - FRA & Sabine ERNST, London - UK

Ablation should be proposed after the first AF episode ?

Pro

H.PÜRERFELLNER, Linz, AT

Con

Isabel DEISENHOFER, Munich, GER

Electroporation : differences between the systems (videos)

J.KORUTH, New-York - USA

Is FA a mappable rythm ?

Pro

A.FRONTERA, Milano - IT

Con

Sabine ERNST, London - UK

Novelties for mapping and ablation in Prism, the last generation MAPPING system

E.ANTER, Cleveland - USA

Discussion 18'

15h30

SESSION 3: THE FIBRILLATING HEART: ATRIAL FIBRILLATION WITH THE SUPPORT OF MICROPORT

Amphithéâtre Bordeaux

F.ANSELME, Rouen - FRA & M.O'NEILL, London - UK

Is PVI enough for persistant AF ablation ?

Pro

M. O’NEILL, London – UK

Con

Claire MARTIN, London - UK

Pre-recorded case: laser balloon ablation

J.M. SELLAL, Nancy - FRA

Discussion 15'

16h30

SESSION 4: THE FIBRILLATING HEART: ATRIAL FIBRILLATION

Amphithéâtre Bordeaux

J-P. ALBENQUE, Toulouse - FRA & A.BERRUEZO, Barcelona - ES

Machine learning for ECG analysis : principles and perspectives

R.DUBOIS, Bordeaux - FRA

AF prediction based on 12 leads surface ECG

P.NOSEWORTHY, Rochester - USA

What can you expect from a smartwatch ?

P.BORDACHAR & M.STRIK, Bordeaux - FRA

Rationale and indication of cardioneural ablation Principe et indication de la cardioneuro ablation

J.DUCHATEAU, Bordeaux - FRA

Discussion 20'

8h30

SESSION 5: THE FIBRILLATING HEART: ATRIAL FIBRILLATION WITH THE SUPPORT OF BIOSENSE WEBSTER

Amphithéâtre Bordeaux

Laurence JESEL-MOREL, Strasbourg - FRA & E.ANTER, Cleveland - USA

Impact of high-power short-duration radiofrequency ablation on long-term lesion durability for atrial fibrillation ablation

E.ANTER, Cleveland - USA

CLOSE vs PFA: expectations from a high-volume ce,ter

M.DUYTSCHAEVER, Bruges - BE

The optimized clinical workflow for pulmonary vein isolation with the radiofrequency balloon

A.ALMORAD, Brussels - BE

Why AF may alter LVEF in some patients and not in other ?

Léna RIVARD, Montréal - CAN

Discussion 20'

9h30

SESSION 6: THE FIBRILLATING HEART: ATRIAL FIBRILLATION

Amphithéâtre Bordeaux

J-C. DEHARO, Marseille - FRA & J.KORUTH, New-York - USA

What is optimal anticoagulation for AF ablation, interaction between DOA and heparine ?

Anne-Céline MARTIN, Paris - FRA

What is the impact of AF on cognitive function ?

Léna RIVARD, Montréal - CAN

MicroBubbles and silent embolic event with PFA vs RF vs Cryo

J.KORUTH, New-York - USA

Pre-recorded case: acute phase per procedural stroke management

G.MARNAT, Bordeaux - FRA

Discussion 20'

11h00

SESSION 7: THE FIBRILLATING HEART: ATRIAL FIBRILLATION

Amphithéâtre Bordeaux

P.MABO, Rennes - FRA & F.EXTRAMIANA, Paris - FRA

What is the cost of an AF ablation in term of carbon emission ?

F.BESSIERE, Lyon - FRA

What can be done to improve EP sustainability ?

Julie BOUSSUGES-ROZE, Bordeaux - FRA

Discussion 10'

11h30

SESSION 1: THE FIBRILLATING HEART: VENTRICULAR ARRHYTHMIAS WITH THE SUPPORT OF BOSTON SCIENTIFIC & BAYLIS

Amphithéâtre Bordeaux

L.FAUCHIER, Tours - FRA

May safer anticoagulants impact LAA Occlusion ?

L.FAUCHIER, Tours - FRA

State of the art and indications from the LAAO ?

J.KORUTH, New-York - USA

The LAAO procedure in practice with regard to the latest technologies

R.ESCHALIER, Clermont-Ferrand - FRA

14h00

SESSION 2: THE FIBRILLATING HEART: VENTRICULAR ARRHYTHMIAS WITH THE SUPPORT OF ABBOTT

Amphithéâtre Bordeaux

T. DE POTTER, Aalst - BE & P.MILLIEZ, Caen - FRA

Novelties in mapping with Ensite X

A. PORTA, Barcelona - ES

Omnipolar mapping for VT ablation

F.SACHER, Bordeaux, FRA

Wavefront discontinuities mapping

R.TUNG, Chicago - USA

How to optimize RF lesion in VT ablation (parameter, half saline, …)?

T.DENEKE, Bad Neustadt - GER

Isthmus identification by CT scan

P.JAÏS, Bordeaux - FRA

Relationship between MRI-defined scar geography and the VT Isthmus

C. DE CHILLOU, Nancy - FRA

Discussion 18'

16h00

SESSION 3: THE FIBRILLATING HEART: VENTRICULAR ARRHYTHMIAS

Amphithéâtre Bordeaux

P.CHEVALIER, Lyon - FRA & E.ANTER, Cleveland - USA

The 2022 ESC Guidelines : Management of VT in patients with a structural heart disease

C. DE CHILLOU, Nancy - FRA

Ablation Guided by Pace-Mapping

J-M. SELLAL, Nancy - FRA

Electroporation in VT ablation

E.ANTER, Cleveland - USA

Ultra-low cryo in VT ablation

T. DE POTTER, Aalst - BE

Anti-arrhythmic effect of SBRT

P. MAURY, Toulouse - FRA

How to optimize targets identification for the treatment of VT by SBRT ?

H.COCHET, Bordeaux - FRA

Discussion 30'

8h30

SESSION 4: THE FIBRILLATING HEART: VENTRICULAR ARRHYTHMIAS

Amphithéâtre Bordeaux

M.HAÏSSAGUERRE, Bordeaux - FRA & V.PROBST, Nantes - FRA

Inducible Purkinje reentry as an important mechanism of VF

M. HAÏSSAGUERRE, Bordeaux - FRA

Mechanisms of VA and risk stratification in patients with mitral valve prolapse

A. SABBAG, Ramat Gan, IL

VT ablation in cardiac sarcoidosis

F. BOGUN, Ann Arbor - USA

Ventricular arrhthmias in arrhythmogenic right/left ventricular CMP

Estelle GANDJBAKHCH, Paris - FRA

Discussion 30'

10h00

SESSION 5: THE FIBRILLATING HEART: VENTRICULAR ARRHYTHMIAS

Amphithéâtre Bordeaux

P. DELLA BELLA, Milano - IT & E.MARIJON, Paris - FRA

PARTITA/PARTITA

P. DELLA BELLA, Milano - IT

How to predict sudden cardiac death ?

X. JOUVEN, Paris - FRA

Survive-VT : Substrate Ablation vs Anti-arrhythmic drugs for scar related VT ablation

A. BERRUEZO, Barcelona - ES

Discussion 30'

SESSIONS DU GROUPE DE RYTHMOLOGIE ET DE STIMULATION CARDIAQUE DE LA SFC

11h30

DIAGNOSTIC DES TACHYCARDIES

Amphithéâtre Bordeaux

S.BOVEDA, Toulouse - FRA & L.FAUCHIER, Tours - FRA

Tachycardie à QRS larges : ventriculaire ou supraventriculaire ?

M. NIRO, Saint-Denis

Tachycardie atriale, JET ou rythme réciproque ?

F. ANSELME, Rouen

AVRT ou AVNRT ?

R. MARTINS, Rennes

12h30

QUIZZ EP AVEC PARTICIPATION DE L'ASSISTANCE ET DISCUSSION (2 CAS PAR DES JEUNES)

Amphithéâtre Bordeaux

J. MANSAROUTI, Brest & P. MAURY, Toulouse - FRA

J. HOURDAN, Marseille

Laura DELSARTE, Montpellier

Sandrine VENIER, Grenoble

13h30

NOUVEAUTES DANS LES RECOMMANDATIONS DE LA MORT SUBITE

Amphithéâtre Bordeaux

Pascal DEFAYE, Grenoble - FRA

Prise en chagre des patients post infarctus

E. MARIJON, Paris

Prise en charge des patients insuffisants cardiaques récemment diagnostiqués

N. LELLOUCHE, Créteil

14h30

CONDUCTION ATRIO-VENTRICULAIRE

Amphithéâtre Bordeaux

O. PIOT, Saint-Denis & D.KLUG, Lille - FRA

Blocs fréquence-dépendants

N. LELLOUCHE, Créteil

Dualité de conduction nodale

J. DUCHÂTEAU, Bordeaux

Conduction cachée

R. GARCIA, Poitiers

Wenckebach alterné

F. EXTRAMIANA, Paris

16h00

VOIES ACCESSOIRES

Amphithéâtre Bordeaux

G. LAURENT, Dijon & Mina AIT SAÏD, Massy - FRA

Kent para-hissien

P. DEFAYE, Grenoble

Faisceau de Kent chez l'enfant

J-L. PASQUIER, Montpellier

Cas cliniques complexes

Peggy JACON, Grenoble